| 000 | 01545 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517094244.0 | ||
| 264 | 0 | _c20171019 | |
| 008 | 201710s 0 0 eng d | ||
| 022 | _a1543-8392 | ||
| 024 | 7 |
_a10.1021/acs.molpharmaceut.6b00081 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMakris, George | |
| 245 | 0 | 0 |
_aDevelopment and Pharmacological Evaluation of New Bone-Targeted (99m)Tc-Radiolabeled Bisphosphonates. _h[electronic resource] |
| 260 |
_bMolecular pharmaceutics _c07 2016 |
||
| 300 |
_a2301-17 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBone and Bones _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aChelating Agents _xchemistry |
| 650 | 0 | 4 |
_aChromatography, High Pressure Liquid _xmethods |
| 650 | 0 | 4 |
_aDiphosphonates _xchemistry |
| 650 | 0 | 4 |
_aDurapatite _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 | _aMCF-7 Cells |
| 650 | 0 | 4 |
_aOrganotechnetium Compounds _xadministration & dosage |
| 650 | 0 | 4 |
_aRadiopharmaceuticals _xchemistry |
| 650 | 0 | 4 |
_aRhenium _xchemistry |
| 650 | 0 | 4 |
_aTechnetium _xchemistry |
| 650 | 0 | 4 | _aTissue Distribution |
| 700 | 1 | _aTseligka, Eirini D | |
| 700 | 1 | _aPirmettis, Ioannis | |
| 700 | 1 | _aPapadopoulos, Minas S | |
| 700 | 1 | _aVizirianakis, Ioannis S | |
| 700 | 1 | _aPapagiannopoulou, Dionysia | |
| 773 | 0 |
_tMolecular pharmaceutics _gvol. 13 _gno. 7 _gp. 2301-17 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/acs.molpharmaceut.6b00081 _zAvailable from publisher's website |
| 999 |
_c26011886 _d26011886 |
||